113 related articles for article (PubMed ID: 1654265)
1. Reversal or nitroglycerin tolerance by the cGMP phosphodiesterase inhibitor zaprinast.
Silver PJ; Pagani ED; de Garavilla L; Van Aller GS; Volberg ML; Pratt PF; Buchholz RA
Eur J Pharmacol; 1991 Jun; 199(1):141-2. PubMed ID: 1654265
[No Abstract] [Full Text] [Related]
2. Reversal of nitroglycerin tolerance in vitro by the cGMP-phosphodiesterase inhibitor zaprinast.
Pagani ED; VanAller GS; O'Connor B; Silver PJ
Eur J Pharmacol; 1993 Oct; 243(2):141-7. PubMed ID: 8276063
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo interactions of nitrovasodilators and zaprinast, a cGMP-selective phosphodiesterase inhibitor.
Merkel LA; Rivera LM; Perrone MH; Lappe RW
Eur J Pharmacol; 1992 May; 216(1):29-35. PubMed ID: 1326438
[TBL] [Abstract][Full Text] [Related]
4. Zaprinast, but not dipyridamole, reverses hemodynamic tolerance to nitroglycerin in vivo.
De Garavilla L; Pagani ED; Buchholz RA; Dundore R; Bode DC; Volberg ML; Jackson KN; Pratt P; Silver PJ
Eur J Pharmacol; 1996 Oct; 313(1-2):89-96. PubMed ID: 8905333
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular activity of WIN 65579, a novel inhibitor of cyclic GMP phosphodiesterase 5.
Silver PJ; Pagani ED; Dundore RL; de Garavilla L; Bode DC; Bacon ER
Eur J Pharmacol; 1998 May; 349(2-3):263-8. PubMed ID: 9671106
[TBL] [Abstract][Full Text] [Related]
6. N omega-nitro-L-arginine attenuates the accumulation of aortic cyclic GMP and the hypotension produced by zaprinast.
Dundore RL; Pratt PF; O'Connor B; Buchholz RA; Pagani ED
Eur J Pharmacol; 1991 Jul; 200(1):83-7. PubMed ID: 1663042
[TBL] [Abstract][Full Text] [Related]
7. Phosphodiesterase isozyme inhibition and the potentiation by zaprinast of endothelium-derived relaxing factor and guanylate cyclase stimulating agents in vascular smooth muscle.
Harris AL; Lemp BM; Bentley RG; Perrone MH; Hamel LT; Silver PJ
J Pharmacol Exp Ther; 1989 May; 249(2):394-400. PubMed ID: 2566675
[TBL] [Abstract][Full Text] [Related]
8. Zaprinast increases cyclic GMP levels in plasma and in aortic tissue of rats.
Dundore RL; Clas DM; Wheeler LT; Habeeb PG; Bode DC; Buchholz RA; Silver PJ; Pagani ED
Eur J Pharmacol; 1993 Nov; 249(3):293-7. PubMed ID: 8287916
[TBL] [Abstract][Full Text] [Related]
9. The mode of vasorelaxing action of melatonin in rabbit aorta.
Satake N; Oe H; Sawada T; Shibata S
Gen Pharmacol; 1991; 22(2):219-21. PubMed ID: 1647340
[TBL] [Abstract][Full Text] [Related]
10. Effect of 3-isobutyl-1-methylxanthine and zaprinast on non-adrenergic non-cholinergic relaxation in the rat gastric fundus.
Barbier AJ; Lefebvre RA
Eur J Pharmacol; 1992 Jan; 210(3):315-23. PubMed ID: 1377130
[TBL] [Abstract][Full Text] [Related]
11. Possible mechanisms of age-associated reduction of vascular relaxation caused by atrial natriuretic peptide.
Moritoki H; Yoshikawa T; Hisayama T; Takeuchi S
Eur J Pharmacol; 1992 Jan; 210(1):61-8. PubMed ID: 1350988
[TBL] [Abstract][Full Text] [Related]
12. Cyclic GMP potentiation by WIN 58237, a novel cyclic nucleotide phosphodiesterase inhibitor.
Silver PJ; Dundore RL; Bode DC; de Garavilla L; Buchholz RA; van Aller G; Hamel LT; Bacon E; Singh B; Lesher GY
J Pharmacol Exp Ther; 1994 Dec; 271(3):1143-9. PubMed ID: 7996419
[TBL] [Abstract][Full Text] [Related]
13. Lack of cross-tolerance between nitroglycerin and endothelium-derived relaxing factor-mediated vasoactive agents in spontaneously hypertensive rats.
De Garavilla L; Volberg ML; Pratt PF; Silver PJ; Buchholz RA
Eur J Pharmacol; 1993 Mar; 234(1):77-82. PubMed ID: 8386094
[TBL] [Abstract][Full Text] [Related]
14. Contribution of activation of K+ channels to glyceryl trinitrate-induced relaxation of rabbit aorta.
Ishibashi T; Kawada T; Kato K; Hamaguchi M; Imai S
Gen Pharmacol; 1995 May; 26(3):543-52. PubMed ID: 7540579
[TBL] [Abstract][Full Text] [Related]
15. Sildenafil inhibits phosphodiesterase type 5 in human clitoral corpus cavernosum smooth muscle.
Park K; Moreland RB; Goldstein I; Atala A; Traish A
Biochem Biophys Res Commun; 1998 Aug; 249(3):612-7. PubMed ID: 9731184
[TBL] [Abstract][Full Text] [Related]
16. Relationship between cyclic guanosine monophosphate accumulation and relaxation of canine trachealis induced by nitrovasodilators.
Zhou HL; Torphy TJ
J Pharmacol Exp Ther; 1991 Sep; 258(3):972-8. PubMed ID: 1679854
[TBL] [Abstract][Full Text] [Related]
17. Lack of effect of zaprinast on methacholine-induced contraction and inositol 1,4,5-trisphosphate accumulation in bovine tracheal smooth muscle.
Chilvers ER; Giembycz MA; Challiss RA; Barnes BJ; Nahorski SR
Br J Pharmacol; 1991 May; 103(1):1119-25. PubMed ID: 1652339
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of tolerance to sodium nitroprusside in rat cultured aortic smooth muscle cells.
Papapetropoulos A; Go CY; Murad F; Catravas JD
Br J Pharmacol; 1996 Jan; 117(1):147-55. PubMed ID: 8825356
[TBL] [Abstract][Full Text] [Related]
19. Biphasic relaxant curves to glyceryl trinitrate in rat aortic rings. Evidence for two mechanisms of action.
Malta E
Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):236-43. PubMed ID: 2566926
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of phosphodiesterase 1A1 expression is associated with the development of nitrate tolerance.
Kim D; Rybalkin SD; Pi X; Wang Y; Zhang C; Munzel T; Beavo JA; Berk BC; Yan C
Circulation; 2001 Nov; 104(19):2338-43. PubMed ID: 11696475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
